Press Release: Acadia Pharmaceuticals to Announce First Quarter Financial Results on May 7, 2025
TD Cowen Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Maintains Target Price $35
TD Cowen Sticks to Its Buy Rating for ACADIA Pharmaceuticals (ACAD)
BofA Securities Maintains ACADIA Pharmaceuticals(ACAD.US) With Hold Rating, Maintains Target Price $18
BMO Capital Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Cuts Target Price to $24
BofA Securities Maintains ACADIA Pharmaceuticals(ACAD.US) With Hold Rating, Announces Target Price $18
Express News | ACADIA Pharmaceuticals Inc : BMO Cuts Target Price to $24 From $31
Fund Update: Assenagon Asset Management S.A. Opened a $60.8M Position in $ACAD Stock
Express News | ACADIA Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Insider Sale: EVP of $ACAD Sells 2,708 Shares
Needham Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Maintains Target Price $28
Express News | Needham Reiterates Buy on ACADIA Pharmaceuticals, Maintains $28 Price Target
ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
RBC Capital Sticks to Its Buy Rating for ACADIA Pharmaceuticals (ACAD)
Is ACADIA Pharmaceuticals Inc. (ACAD) the Best Nasdaq Stock Under $20 to Buy Now?
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
Morgan Stanley Assumes ACADIA Pharmaceuticals at Equal-Weight, Maintains Price Target of $20
ACADIA Pharmaceuticals Analyst Ratings
Morgan Stanley Maintains ACADIA Pharmaceuticals(ACAD.US) With Hold Rating, Maintains Target Price $20